tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

SONN Stock Latest News

Sonnet BioTherapeutics Expands Phase 1 Study for SON-1010
Company AnnouncementsSonnet BioTherapeutics Expands Phase 1 Study for SON-1010
5m ago
8K
SONN
Sonnet BioTherapeutics expands Phase 1 SB101 trial
PremiumThe Fly
Sonnet BioTherapeutics expands Phase 1 SB101 trial
29m ago
SONN
Sonnet BioTherapeutics reports FY24 EPS ($11.35) vs. ($145.13) last year
PremiumThe Fly
Sonnet BioTherapeutics reports FY24 EPS ($11.35) vs. ($145.13) last year
1M ago
SONN
Sonnet BioTherapeutics sees cash runway into July 2025
PremiumThe Fly
Sonnet BioTherapeutics sees cash runway into July 2025
1M ago
SONN
SONN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
SONN Earnings this Week: How Will it Perform?
1M ago
SONN
Sonnet BioTherapeutics announces $3.9M registered direct offering
PremiumThe FlySonnet BioTherapeutics announces $3.9M registered direct offering
1M ago
SONN
Sonnet announces safety data following SON-1010 monotherapy dose escalation
Premium
The Fly
Sonnet announces safety data following SON-1010 monotherapy dose escalation
1M ago
SONN
Sonnet BioTherapeutics Advances in SON-1010 Phase 1 Trial
Premium
Company Announcements
Sonnet BioTherapeutics Advances in SON-1010 Phase 1 Trial
1M ago
8K
SONN
Sonnet BioTherapeutics Reports Promising Data for SON-1010
PremiumCompany Announcements
Sonnet BioTherapeutics Reports Promising Data for SON-1010
2M ago
8K
SONN
Sonnet BioTherapeutics announces publication on SON-1010 development
PremiumThe Fly
Sonnet BioTherapeutics announces publication on SON-1010 development
2M ago
SONN
Sonnet BioTherapeutics releases ‘What this Means’ segment
PremiumThe Fly
Sonnet BioTherapeutics releases ‘What this Means’ segment
2M ago
SONN
Sonnet BioTherapeutics prices $5M at-the-market offering
PremiumThe Fly
Sonnet BioTherapeutics prices $5M at-the-market offering
3M ago
SONN
Sonnet BioTherapeutics Secures Patent for Cancer Drugs
PremiumCompany AnnouncementsSonnet BioTherapeutics Secures Patent for Cancer Drugs
3M ago
8K
SONN
Sonnet BioTherapeutics announces USPTO issued U.S. patent on IL-18
Premium
The Fly
Sonnet BioTherapeutics announces USPTO issued U.S. patent on IL-18
3M ago
SONN
Sonnet BioTherapeutics files to sell common stock, warrants, no amount given
Premium
The Fly
Sonnet BioTherapeutics files to sell common stock, warrants, no amount given
3M ago
SONN
Sonnet BioTherapeutics Maintains Nasdaq Listing Compliance
PremiumCompany Announcements
Sonnet BioTherapeutics Maintains Nasdaq Listing Compliance
3M ago
8K
SONN
Sonnet BioTherapeutics regains compliance with Nasdaq
PremiumThe Fly
Sonnet BioTherapeutics regains compliance with Nasdaq
3M ago
SONN
Sonnet BioTherapeutics’ Strategic Deal to Develop DPN Treatment
PremiumCompany Announcements
Sonnet BioTherapeutics’ Strategic Deal to Develop DPN Treatment
3M ago
8K
SONN
Sonnet BioTherapeutics, Alkem enter licensing agreement for SON-080
PremiumThe Fly
Sonnet BioTherapeutics, Alkem enter licensing agreement for SON-080
3M ago
SONN
Sonnet BioTherapeutics receives funding through NJEDA, Australia tax programs
PremiumThe FlySonnet BioTherapeutics receives funding through NJEDA, Australia tax programs
4M ago
SONN
Sonnet BioTherapeutics announces launch of CEO Corner platform
Premium
The Fly
Sonnet BioTherapeutics announces launch of CEO Corner platform
4M ago
SONN
Sonnet Biotherapeutics Holdings Inc trading halted, news pending
Premium
The Fly
Sonnet Biotherapeutics Holdings Inc trading halted, news pending
4M ago
SONN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >